Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Alcoholic Liver Disease.

Abittan¹, Lieber

¹Mount Sinai Medical Center, 1 Gustave L. Levey Place, New York, NY 10029.

Current Treatment Options in Gastroenterology

|November 30, 2000

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Carbon nanotube-based nonvolatile random access memory for molecular computing

Science (New York, N.Y.)·2000

Same author

Nanotube nanotweezers

Science (New York, N.Y.)·1999

Same author

A laser ablation method for the synthesis of crystalline semiconductor nanowires

Science (New York, N.Y.)·1998

Same author

Vortex Lattice Structure in Bi2Sr2CaCu2O8+ delta at High Temperatures.

Physical review letters·1996

Same author

Asymptotic wave function for three charged particles in the continuum.

Physical review. A, Atomic, molecular, and optical physics·1996

Same author

Nanotribology and Nanofabrication of MoO3 Structures by Atomic Force Microscopy

Science (New York, N.Y.)·1996

Same journal

Esophageal Disorders in the Older Adult.

Current treatment options in gastroenterology·2025

Same journal

Endobariatrics: a Still Underutilized Weight Loss Tool.

Current treatment options in gastroenterology·2023

Same journal

Management of Post Ablative Barrett's Esophagus: a Review of Current Practices and Look at Emerging Technologies.

Current treatment options in gastroenterology·2023

Same journal

Inflammatory Bowel Disease Therapy and Venous Thromboembolism.

Current treatment options in gastroenterology·2023

Same journal

Ileal Pouch-Anal Anastomosis in the Older Adult: a Review of Postoperative Outcomes and Pouchitis Treatment.

Current treatment options in gastroenterology·2023

Same journal

Celiac Disease in the Elderly.

Current treatment options in gastroenterology·2023

See all related articles

Early alcoholism detection using biochemical markers like carbohydrate-deficient transferrin (CDT) aids prevention. Liver biopsy is crucial for heavy drinkers with liver injury to identify fibrosis and initiate targeted treatments for alcohol-related liver disease.

Area of Science:

Hepatology
Biochemistry
Clinical Medicine

Background:

Traditional alcoholism treatment focuses on psychological and behavioral issues.
Early detection and intervention are crucial for managing alcohol's effects.
Biochemical markers like carbohydrate-deficient transferrin (CDT) can identify heavy alcohol use.

Purpose of the Study:

To explore early detection methods for alcoholism.
To identify individuals at risk for alcohol-related liver disease.
To outline effective treatment strategies for alcohol-induced liver injury and fibrosis.

Main Methods:

Utilizing biochemical markers such as carbohydrate-deficient transferrin (CDT) for heavy drinking detection.
Screening heavy alcohol users for medical complications.

Related Experiment Videos

Performing liver biopsy to diagnose perivenular fibrosis in at-risk individuals.

Main Results:

Carbohydrate-deficient transferrin (CDT) serves as a biochemical marker for heavy drinking.
Liver biopsy is essential for identifying perivenular fibrosis, a precursor to cirrhosis.
S-adenosylmethionine and polyenylphosphatidylcholine show promise in preclinical and clinical studies for liver injury and fibrosis.
Prednisolone improves survival in severe alcoholic hepatitis.

Conclusions:

Early detection of alcoholism through biochemical markers and medical screening is vital.
Liver biopsy is critical for diagnosing early-stage liver damage in heavy drinkers.
Intensive treatment, including nutritional support and potential novel therapies, is recommended for alcohol-induced liver disease.